Healius Limited

ASX (AUD): Healius Limited (HLS)

Last Price

0.935

Today's Change

+0.10 (11.97%)

Day's Change

0.835 - 0.935

Trading Volume

38,175,265

Overview

Market Cap

678 Million

Shares Outstanding

726 Million

Avg Volume

6,157,049

Avg Price (50 Days)

0.78

Avg Price (200 Days)

1.18

PE Ratio

-1.20

EPS

-0.78

Earnings Announcement

18-Feb-2026

Previous Close

0.83

Open

0.84

Day's Range

0.835 - 0.935

Year Range

0.6625 - 1.86

Trading Volume

38,175,265

Price Change Highlight

1 Day Change

11.98%

5 Day Change

15.43%

1 Month Change

16.88%

3 Month Change

-2.09%

6 Month Change

-30.22%

Ytd Change

-33.21%

1 Year Change

-42.28%

3 Year Change

-73.81%

5 Year Change

-69.04%

10 Year Change

-74.80%

Max Change

4.12%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment